vs
Side-by-side financial comparison of Azenta, Inc. (AZTA) and PATHWARD FINANCIAL, INC. (CASH). Click either name above to swap in a different company.
PATHWARD FINANCIAL, INC. is the larger business by last-quarter revenue ($173.1M vs $148.6M, roughly 1.2× Azenta, Inc.). PATHWARD FINANCIAL, INC. runs the higher net margin — 20.3% vs -10.4%, a 30.7% gap on every dollar of revenue. On growth, Azenta, Inc. posted the faster year-over-year revenue change (0.8% vs -0.2%). PATHWARD FINANCIAL, INC. produced more free cash flow last quarter ($104.1M vs $14.7M). Over the past eight quarters, Azenta, Inc.'s revenue compounded faster (4.4% CAGR vs -18.0%).
Azenta, was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics.
Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.
AZTA vs CASH — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $148.6M | $173.1M |
| Net Profit | $-15.4M | $35.2M |
| Gross Margin | 42.9% | — |
| Operating Margin | -4.9% | 24.6% |
| Net Margin | -10.4% | 20.3% |
| Revenue YoY | 0.8% | -0.2% |
| Net Profit YoY | -15.7% | 11.9% |
| EPS (diluted) | $-0.34 | $1.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.6M | $173.1M | ||
| Q3 25 | $159.2M | $186.7M | ||
| Q2 25 | $143.9M | $195.8M | ||
| Q1 25 | $143.3M | $274.8M | ||
| Q4 24 | $147.4M | $182.6M | ||
| Q3 24 | $150.6M | $179.5M | ||
| Q2 24 | $144.3M | $188.6M | ||
| Q1 24 | $136.4M | $257.6M |
| Q4 25 | $-15.4M | $35.2M | ||
| Q3 25 | $50.9M | $38.8M | ||
| Q2 25 | $-48.0M | $42.1M | ||
| Q1 25 | $-47.7M | $75.0M | ||
| Q4 24 | $-11.0M | $30.0M | ||
| Q3 24 | $-6.6M | $33.5M | ||
| Q2 24 | $-6.6M | $44.9M | ||
| Q1 24 | $-137.4M | $69.9M |
| Q4 25 | 42.9% | — | ||
| Q3 25 | 45.4% | — | ||
| Q2 25 | 46.2% | — | ||
| Q1 25 | 43.8% | — | ||
| Q4 24 | 46.7% | — | ||
| Q3 24 | 45.5% | — | ||
| Q2 24 | 44.8% | — | ||
| Q1 24 | 43.8% | — |
| Q4 25 | -4.9% | 24.6% | ||
| Q3 25 | 1.2% | 25.9% | ||
| Q2 25 | -1.3% | 24.1% | ||
| Q1 25 | -12.7% | 33.2% | ||
| Q4 24 | -5.9% | 19.8% | ||
| Q3 24 | -3.1% | 20.9% | ||
| Q2 24 | -4.9% | 27.1% | ||
| Q1 24 | -18.1% | 33.8% |
| Q4 25 | -10.4% | 20.3% | ||
| Q3 25 | 32.0% | 20.8% | ||
| Q2 25 | -33.4% | 21.5% | ||
| Q1 25 | -33.3% | 27.3% | ||
| Q4 24 | -7.5% | 16.4% | ||
| Q3 24 | -4.4% | 18.7% | ||
| Q2 24 | -4.5% | 23.8% | ||
| Q1 24 | -100.8% | 27.1% |
| Q4 25 | $-0.34 | $1.57 | ||
| Q3 25 | $1.12 | $1.69 | ||
| Q2 25 | $-1.05 | $1.81 | ||
| Q1 25 | $-1.04 | $3.14 | ||
| Q4 24 | $-0.25 | $1.23 | ||
| Q3 24 | $-0.25 | $1.34 | ||
| Q2 24 | $-0.12 | $1.78 | ||
| Q1 24 | $-2.48 | $2.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $336.6M | $331.2M |
| Total DebtLower is stronger | — | $33.5M |
| Stockholders' EquityBook value | $1.7B | $854.5M |
| Total Assets | $2.1B | $7.6B |
| Debt / EquityLower = less leverage | — | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $336.6M | $331.2M | ||
| Q3 25 | $279.8M | $120.6M | ||
| Q2 25 | $270.0M | $258.3M | ||
| Q1 25 | $253.6M | $254.2M | ||
| Q4 24 | $377.5M | $597.4M | ||
| Q3 24 | $280.0M | $158.3M | ||
| Q2 24 | $336.5M | $298.9M | ||
| Q1 24 | $353.5M | $347.9M |
| Q4 25 | — | $33.5M | ||
| Q3 25 | — | $33.5M | ||
| Q2 25 | — | $33.4M | ||
| Q1 25 | — | $33.4M | ||
| Q4 24 | — | $33.4M | ||
| Q3 24 | — | $33.4M | ||
| Q2 24 | — | $33.3M | ||
| Q1 24 | — | $33.4M |
| Q4 25 | $1.7B | $854.5M | ||
| Q3 25 | $1.7B | $858.0M | ||
| Q2 25 | $1.7B | $819.0M | ||
| Q1 25 | $1.7B | $814.7M | ||
| Q4 24 | $1.7B | $758.3M | ||
| Q3 24 | $1.8B | $822.5M | ||
| Q2 24 | $2.0B | $748.4M | ||
| Q1 24 | $2.2B | $719.5M |
| Q4 25 | $2.1B | $7.6B | ||
| Q3 25 | $2.1B | $7.2B | ||
| Q2 25 | $2.0B | $7.2B | ||
| Q1 25 | $2.0B | $7.0B | ||
| Q4 24 | $2.0B | $7.6B | ||
| Q3 24 | $2.1B | $7.5B | ||
| Q2 24 | $2.3B | $7.5B | ||
| Q1 24 | $2.6B | $7.4B |
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.04× | ||
| Q2 25 | — | 0.04× | ||
| Q1 25 | — | 0.04× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | 0.05× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.8M | $108.3M |
| Free Cash FlowOCF − Capex | $14.7M | $104.1M |
| FCF MarginFCF / Revenue | 9.9% | 60.1% |
| Capex IntensityCapex / Revenue | 4.2% | 2.4% |
| Cash ConversionOCF / Net Profit | — | 3.08× |
| TTM Free Cash FlowTrailing 4 quarters | $30.9M | $616.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.8M | $108.3M | ||
| Q3 25 | $2.2M | $303.7M | ||
| Q2 25 | $25.8M | $30.4M | ||
| Q1 25 | $14.4M | $188.3M | ||
| Q4 24 | $29.8M | $-71.7M | ||
| Q3 24 | $17.7M | $143.1M | ||
| Q2 24 | $9.8M | $113.2M | ||
| Q1 24 | $8.7M | $203.0M |
| Q4 25 | $14.7M | $104.1M | ||
| Q3 25 | $-5.7M | $300.3M | ||
| Q2 25 | $15.0M | $27.7M | ||
| Q1 25 | $7.0M | $184.7M | ||
| Q4 24 | $22.0M | $-73.8M | ||
| Q3 24 | $8.3M | $138.8M | ||
| Q2 24 | $1.3M | $111.0M | ||
| Q1 24 | $428.0K | $201.3M |
| Q4 25 | 9.9% | 60.1% | ||
| Q3 25 | -3.6% | 160.9% | ||
| Q2 25 | 10.4% | 14.1% | ||
| Q1 25 | 4.9% | 67.2% | ||
| Q4 24 | 15.0% | -40.4% | ||
| Q3 24 | 5.5% | 77.3% | ||
| Q2 24 | 0.9% | 58.8% | ||
| Q1 24 | 0.3% | 78.1% |
| Q4 25 | 4.2% | 2.4% | ||
| Q3 25 | 4.9% | 1.8% | ||
| Q2 25 | 7.5% | 1.4% | ||
| Q1 25 | 5.2% | 1.3% | ||
| Q4 24 | 5.3% | 1.1% | ||
| Q3 24 | 6.2% | 2.4% | ||
| Q2 24 | 5.9% | 1.2% | ||
| Q1 24 | 6.1% | 0.7% |
| Q4 25 | — | 3.08× | ||
| Q3 25 | 0.04× | 7.83× | ||
| Q2 25 | — | 0.72× | ||
| Q1 25 | — | 2.51× | ||
| Q4 24 | — | -2.39× | ||
| Q3 24 | — | 4.27× | ||
| Q2 24 | — | 2.52× | ||
| Q1 24 | — | 2.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AZTA
| Multiomics | $67.2M | 45% |
| Core Products | $47.6M | 32% |
| Sample Repository Solutions | $33.8M | 23% |
CASH
| Consumer | $103.0M | 59% |
| Payment Card And Deposit Fees | $30.1M | 17% |
| Other | $24.2M | 14% |
| Rental Income | $11.6M | 7% |
| Commercial | $4.2M | 2% |
